Dataset opportunity
Corcym — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Corcym, usable for Diagnostic AI and Computer Vision.
Score
63.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Medical Imaging market = $1.75 billion in 2024, CAGR 30%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Corcym holds a proprietary Medical Imaging Dataset, featuring image modalities derived from clinical trials and enriched with corresponding `medical_records` and `business_records`. This curated, high-quality collection is structured for developing and validating Diagnostic AI algorithms, offering significant potential in the cardiovascular field where Corcym specializes.
The business value is anchored in the rapidly expanding AI in Medical Imaging market, which was valued at $1.75 billion in 2024 and is projected to grow at a remarkable CAGR of 30%. [6] Despite the inherent access complexities, such as strict GDPR/HIPAA compliance and shared data ownership, the regulatory-grade quality and rarity of this data make it an exceptionally valuable asset for AI developers seeking to capture a share of this high-growth market. ⚠ Diligence (valuable data, access to negotiate): Clinical data involves sensitive patient health information (PHI) requiring strict GDPR/HIPAA compliance; Data ownership for clinical trials may be shared with healthcare providers or research institutions; Highly regulated medical device industry requires specific data governance for secondary use · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence indicates Corcym possesses a proprietary dataset of clinical evidence, including medical imagery, centered on structural heart disease and related medical devices. This type of specialized data is in high demand from diagnostic AI developers seeking to train and validate algorithms for advanced cardiac applications. In a global AI in Medical Imaging market projected to reach $1.75 billion in 2024 and growing at 30% annually, access to such a rare dataset offers a significant competitive advantage. It represents a unique opportunity to build next-generation diagnostic tools backed by data from an established medical device innovator.
See dimension details ↓- Dataset Specificity78
dominant 'medical_records', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
Buyer demand for high-quality medical imaging data is exceptionally high, driven by the AI in Medical Imaging market's aggressive expansion at a 30% CAGR. [6]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit75
✓ good target — Corcym is a good target as it manufactures and sells surgical heart valves, generating valuable clinical and device performance data as a byproduct of its core operational business, and does not appear to sell this data or derived intelligence as a product. Issues: With ~850 employees, the company is larger than a typical SME, which might affect decision-making speed.; The company was formed from a carve-out and is backed by private equity, which could imply a more structured, less 'dormant' approach to data assets, although t
- Deep Qualification80
✓ pass — Corcym is a medical device manufacturer whose business model is based on selling cardiac surgery products; it does not sell data. It holds valuable clinical and imaging data as a byproduct of R&D and post-market studies, but ownership is complex and likely shared with research partners, making licensing rights for secondary use unclear.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
The company holds clinical evidence, likely including medical images, from the development and validation of its heart valve devices, a critical asset for training diagnostic AI models on specific cardiac conditions.
Industrial data
This evidence points to performance and engineering data from the company's precision-engineered medical devices, which can be used to develop predictive models for device outcomes.
business_records
Corporate documents confirm the data originates from a global medical device company with a specific focus on the structural heart sector, ensuring the dataset's relevance and provenance.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Corcym Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.75 billion in 2024, CAGR 30% (source: Roots Analysis). Investment score 63.1/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Smartct — Downloadable Data Asset Opportunity
View opportunity →healthcareFusixbiotech — Industrial Operations Dataset Opportunity
View opportunity →healthcareMeditek — Maintenance Logs Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read